Frederick M. Kmiecik

Frederick M. Kmiecik serves as a Contracting Officer responsible for managing complex procurements in the medical device and diagnostic manufacturing sectors. He plays a critical role in ensuring the agency’s acquisition objectives align with federal procurement regulations, particularly in the acquisition of specialized healthcare products. His portfolio primarily encompasses contracts governed by FAR Part 12 and Part 13, focusing on commercial off-the-shelf (COTS) medical equipment, in-vitro diagnostic substances, and surgical instruments. Kmiecik’s expertise lies in navigating technical specifications, ensuring regulatory compliance, and facilitating timely contract awards to meet mission-critical healthcare needs. While specific contractor relationships are not publicly enumerated, Kmiecik’s procurement patterns indicate consistent engagement with manufacturers holding relevant ISO and FDA certifications, particularly those capable of delivering high-compliance, low-volume medical products. His working relationships reflect a preference for vendors with proven track records in quality management systems and supply chain resilience, often requiring adherence to stringent performance metrics and post-award surveillance protocols. Kmiecik demonstrates a strong commitment to small business participation, with 16.7% of his acquisitions designated as total small business set-asides under FAR 19.5. His contracting approach prioritizes socioeconomic goals by directing eligible opportunities to small businesses, while the majority of his awards remain open to full and open competition, reflecting a balanced strategy between market efficiency and statutory small business mandates. His primary industry focus centers on NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing), with significant activity also in NAICS 339112 (Surgical and Medical Instrument Manufacturing) and 339113 (Surgical Appliance and Supplies Manufacturing). He routinely procures precision-engineered medical devices, diagnostic reagents, and sterile surgical supplies requiring regulatory clearance, demonstrating deep technical familiarity with FDA-regulated product categories and the lifecycle requirements of clinical-grade medical equipment.